{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:24:45Z","timestamp":1786983885499,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005977","name":"Kaiser Permanente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","academicpedsjnl.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Pediatrics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.acap.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:34:38Z","timestamp":1709728478000},"page":"995-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["On- and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre- to Post-COVID-19"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-2712","authenticated-orcid":false,"given":"Brianna","family":"Costales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Penfold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Spalding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-4998","authenticated-orcid":false,"given":"Esti","family":"Iturralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acap.2024.03.003_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/camh.12501","article-title":"Review: mental health impacts of the COVID-19 pandemic on children and youth - a systematic review","volume":"27","author":"Samji","year":"2022","journal-title":"Child Adolesc Ment Health"},{"key":"10.1016\/j.acap.2024.03.003_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapsychiatry.2022.4165","article-title":"Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults","volume":"80","author":"Bliddal","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.acap.2024.03.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.886652","article-title":"Psychotropic medication use before and during COVID-19: a population-wide study","volume":"13","author":"Leong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.acap.2024.03.003_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/cap.2020.0190","article-title":"Trends over time in antipsychotic initiation at a large children's health care system","volume":"31","author":"Chavez","year":"2021","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.acap.2024.03.003_bib5","first-page":"1035","article-title":"Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016","volume":"27","author":"Chen","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.acap.2024.03.003_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-na\u00efve patients","volume":"53","author":"Arango","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.acap.2024.03.003_bib7","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.20220151","article-title":"Cardiometabolic monitoring and sociodemographic and clinical characteristics of youths prescribed antipsychotic medications","author":"Hsueh","year":"2023","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.acap.2024.03.003_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.acap.2024.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112818","article-title":"Antipsychotics in the management of disruptive behavior disorders in children and adolescents: an update and critical review","volume":"10","author":"Rajkumar","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.acap.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","article-title":"Treatment of young people with antipsychotic medications in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.acap.2024.03.003_bib11","series-title":"Off-Label Use of Atypical Antipsychotics: An Update","article-title":"AHRQ Comparative Effectiveness Reviews","author":"Maglione","year":"2011"},{"key":"10.1016\/j.acap.2024.03.003_bib12","unstructured":"Pillay J, Boylan K, Carrey N, et al. First- and second-generation antipsychotics in children and young adults: systematic review update. Comparative Effectiveness Review No. 184. (Prepared by the University of Alberta Evidence-based Practice Center under Contract No. 290-2015-00001-I.) AHRQ Publication No. 17-EHC001-EF. Rockville, MD: Agency for Healthcare Research and Quality; March 2017. Errata January 2018. \u3008https:\/\/effectivehealthcare.ahrq.gov\/sites\/default\/files\/antipsychotics-children-update_executive.pdf\u3009. 2017."},{"key":"10.1016\/j.acap.2024.03.003_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaac.2020.09.023","article-title":"Trends in antipsychotic medication use in young privately insured children","volume":"60","author":"Bushnell","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.acap.2024.03.003_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.acap.2024.03.003_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/cap.2022.0037","article-title":"Psychotropic prescriptions during the COVID-19 pandemic among U.S. children and adolescents receiving mental health services","volume":"32","author":"Amill-Rosario","year":"2022","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.acap.2024.03.003_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15585\/mmwr.su7201a6","article-title":"Suicidal thoughts and behaviors among high school students \u2014 Youth Risk Behavior Survey, United States, 2021","volume":"72","author":"Gaylor","year":"2023","journal-title":"MMWR Suppl"},{"key":"10.1016\/j.acap.2024.03.003_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1192\/bjp.2022.112","article-title":"Impact of the COVID-19 pandemic on psychotropic medication uptake: time-series analysis of a population-wide cohort","volume":"221","author":"Maguire","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.acap.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1186\/s12889-021-12098-5","article-title":"Gender differences in psychosocial status of adolescents during COVID-19: a six-country cross-sectional survey in Asia Pacific","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.acap.2024.03.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106184","article-title":"Safer use of antipsychotics in youth (SUAY) pragmatic trial protocol","volume":"99","author":"Penfold","year":"2020","journal-title":"Contemp Clin Trials"}],"container-title":["Academic Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187628592400072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187628592400072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T08:55:50Z","timestamp":1722070550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187628592400072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S187628592400072X"],"URL":"https:\/\/doi.org\/10.1016\/j.acap.2024.03.003","relation":{},"ISSN":["1876-2859"],"issn-type":[{"value":"1876-2859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On- and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre- to Post-COVID-19","name":"articletitle","label":"Article Title"},{"value":"Academic Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acap.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 by Academic Pediatric Association All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}